GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.B. Chemicals & Pharmaceuticals Ltd (BOM:506943) » Definitions » Deferred Tax

J.B. Chemicals & Pharmaceuticals (BOM:506943) Deferred Tax : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 1991. Start your Free Trial

What is J.B. Chemicals & Pharmaceuticals Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

J.B. Chemicals & Pharmaceuticals's change in deferred tax for the three months ended in Mar. 2025 was ₹0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.


J.B. Chemicals & Pharmaceuticals Deferred Tax Historical Data

The historical data trend for J.B. Chemicals & Pharmaceuticals's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.B. Chemicals & Pharmaceuticals Deferred Tax Chart

J.B. Chemicals & Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

J.B. Chemicals & Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

J.B. Chemicals & Pharmaceuticals Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


J.B. Chemicals & Pharmaceuticals Deferred Tax Related Terms

Thank you for viewing the detailed overview of J.B. Chemicals & Pharmaceuticals's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.


J.B. Chemicals & Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Appa Saheb Marathe Marg, Cnergy IT Park, Unit A2, 3rd floor, Unit A, 8th floor, Prabhadevi, Mumbai, MH, IND, 400 025
J.B. Chemicals & Pharmaceuticals Ltd is an India-based pharmaceutical company. It manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). The company's products include various pharmaceutical dosage forms like tablets, injectable, creams, ointments, lozenges, herbal liquids, and capsules. It also offers services including optimization of formulations, scale-up services, stability testing, regulatory support, packaging design, and commercial production. The group derives revenue from the manufacturing and marketing of a diverse range of pharmaceutical products. The company sells its products in India and also exports them to other international countries.

J.B. Chemicals & Pharmaceuticals Headlines

No Headlines